L5 Capital Inc. - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-12-12
06:06 am
Purchase		2024-12-1013DBriaCell Therapeutics Corp.
BCTX		L5 Capital Inc.26,876
10.700%		517increase
(+1.96%)		Filing
History
2024-12-10
06:06 am
Purchase		2024-12-0613DBriaCell Therapeutics Corp.
BCTX		L5 Capital Inc.26,359
10.500%		767increase
(+3.00%)		Filing
History
2024-12-05
07:45 am
Purchase		2024-12-0313DBriaCell Therapeutics Corp.
BCTX		L5 Capital Inc.25,592
10.000%		7,573increase
(+42.03%)		Filing
History
2024-05-24
08:58 am
Purchase		2024-05-1413DBriaCell Therapeutics Corp.
BCTX		L5 Capital Inc.18,020
14.700%		7,820increase
(+76.66%)		Filing
History
2022-07-18
09:00 am
Purchase		2022-07-1813GHTG Molecular Diagnostics, Inc.
HTGM		L5 Capital Inc.97,500
10.590%		47,500increase
(+95.00%)		Filing
History
2022-06-29
09:00 am
Purchase		2022-06-2813GHTG Molecular Diagnostics, Inc.
HTGM		L5 Capital Inc.50,000
5.400%		50,000increase
(New Position)		Filing
History
2021-09-07
4:05 pm
Unchanged		2021-09-0113DBriaCell Therapeutics Corp.
BCTX		L5 Capital Inc.10,200
10.000%		0
(Unchanged)		Filing
History
2021-08-04
09:43 am
Purchase		2021-08-0313GBriaCell Therapeutics Corp.
BCTX		L5 Capital Inc.10,200
10.000%		5,367increase
(+111.03%)		Filing
History
2021-06-28
4:15 pm
Purchase		2021-06-2113GBriaCell Therapeutics Corp.
BCTX		L5 Capital Inc.4,833
5.010%		4,833increase
(New Position)		Filing
History